Literature DB >> 115259

Relation between ulcerogenic activity of various NSAID and their potency as inhibitors of prostaglandin synthesis in vivo.

K M Strub, R K Müller.   

Abstract

A series of non-steroidal anti-inflammatory drugs (NSAID) and a few other agents were evaluated for their ability to: 1) reduce the acute toxicity of intravenously injected arachidonic acid (AA) in mice; 2) prevent castor oil-induced diarrhoea in mice; 3) enhance the formation of gastric mucosal erosions by a water stress in rats. A correlation between the activity in the three tests has been found for most NSAID studied, and the results point to inhibition of cyclooxygenase as a common mechanism of action.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 115259

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN: 0379-0363


  5 in total

1.  Origins and impact of the term 'NSAID'.

Authors:  Jonas Kure Buer
Journal:  Inflammopharmacology       Date:  2014-07-27       Impact factor: 4.473

2.  Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

Authors:  G Haeusler; M Gerold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  Therapeutic effect of Linum usitatissimum (flaxseed/linseed) fixed oil on acute and chronic arthritic models in albino rats.

Authors:  Gaurav Kaithwas; Dipak K Majumdar
Journal:  Inflammopharmacology       Date:  2010-02-16       Impact factor: 4.473

4.  Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?

Authors:  C N Berry; M Prouteau; K G Lloyd
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

5.  Inhibition of arachidonic acid release as the mechanism by which glucocorticoids inhibit endotoxin-induced diarrhoea.

Authors:  N S Doherty
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.